GlassScriptPhysician profile
Irwin White-Gittens
NPI 1144635418
$13,005.24
in general payments reported to CMS, 2019-2025
24 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $439 · 2022: $3,815 · 2023: $4,899 · 2024: $1,883 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,728 · Travel and Lodging: $3,332 · Consulting Fee: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,728.37 |
| Travel and Lodging | $3,331.99 |
| Consulting Fee | $690.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,693.29 | 2023-2024 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $1,712.13 | 2022-2023 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Silk Road Medical, INC. | $1,608.73 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $1,572.41 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lemaitre Vascular, INC. | $1,212.46 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Restoreflow |
| Cardiovascular Systems INC. | $589.87 | 2022 | |
| Medtronic Vascular, INC. | $439.14 | 2020 | |
| Shockwave Medical, INC | $371.19 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $368.17 | 2024-2025 | General - Atherectomy, General - Vascular Intervention, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $363.91 | 2023-2024 | Alto Abdominal Stent Graft System |
| Medtronic, INC. | $235.52 | 2022-2025 | Heli-Fx Endoanchor System, Endurant Iis, Ellipsys Vascular Access System |
| Ossur Americas, INC. | $183.21 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $177.07 | 2024-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Terumo Medical Corporation | $110.10 | 2024 | Azur Cx Detachable |
| Smith+Nephew, INC. | $97.68 | 2023-2025 | Collagenase Santyl, Grafix Pl, Oasis |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $96.85 | 2025 | Puraply Wound Matrix |
| Kerecis Limited | $31.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $29.18 | 2025 | |
| Humacyte Global, INC. | $23.65 | 2025 | Symvess |
| Abbvie INC. | $20.85 | 2022 | |
| Ethicon US, LLC | $19.93 | 2024 | Dermabond Prineo, Stratafix, Prolene |
| Cook Medical LLC | $17.57 | 2024 | Zenith Spiral-Z |
| Angiodynamics, INC. | $16.43 | 2022 | |
| Becton, Dickinson and Company | $14.12 | 2024 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin White-Gittens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.